Brisbane Clinical Trials

The Skin Barrier Study

The study medication is a potential new treatment for Immunologic and Inflammatory Diseases.

4 nights
12 visits

Study Objective:

  • The study drug is a new potential treatment for a variety of skin related conditions diseases caused by the immune system malfunctioning. Known as autoimmune and/or autoinflammatory diseases. These conditions often cause a variety of adverse symptoms which can be painful and prone to infection.
  • The goal of the study medication is to be an additional treatment option which can prevent skin conditions at the source of the immune response.
  • The study medication will be given as an injection under the skin, and participants will receive just one single dose.

Importance of Treatment:

  • Developing treatments that can prevent the body's immune system from attacking itself (one way or another) is crucial for improving the lives of millions affected globally.

Clinical Trial Details:

  • An independent ethics committee has approved this clinical trial.
  • Participants will be reimbursed for their time

Call us on 1800 243 733 to discuss your eligibility today!

Eligibility

Biological Sex Male or Female
Age 18 – 65 years old
BMI 18 - 32 kg/m²
Weight <120kg
Medical History No significant medical history
Medications Not taking any prescription medication (except for hormonal contraception)
Smoking History Non-smokers OR smoking less than 5 cigarettes/day between outpatient visits